Navigation Links
Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Hodgkin's Lymphoma
Date:8/21/2007

on a timely basis and fluctuations in currency exchange rates. Additional risks and uncertainties relating to Pharmion and its business can be found in the "Risk Factors" section of Pharmion's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2007, its Annual Report on Form 10-K for the year ended December 31, 2006 and in our other filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date on which they are made, and Pharmion undertakes no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future developments or otherwise.


'/>"/>
SOURCE Pharmion Corporation
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
2. Pharmion to Present Clinical Data on Commercial and Pipeline Products at 2007 American Society of Clinical Oncology (ASCO) Meeting
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Sygnis Pharma AG announces date for presentation of clinical results
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2008)...New study finds the majority of acute lymphoblasti... present at the time of diagnosis , , MEMPH...ntists at St. Jude Children,s Research Hospital ha...ancer cells of children with acute lymphoblastic l...rs a pathway to designing treatments for ALL relap...
(Date:11/26/2008)...Study Expanded to 406 Subjects , , FRANKLIN...tems Inc. (OTC Bulletin Board: PLCSF) announced to...S. Food and Drug Administration (FDA) for its U.S....ompany,s RenalGuard System(TM) and associated the...athy (CIN). , , The FDA also approved PLC,s...
(Date:11/25/2008)...Results reveal most respondents against expanding ..., , LITTLE FALLS, N.J., Nov. 25 /PRNewswire...atin may lower the cardiovascular risk of healthy ...ersal statin use in older adults, according to a n...e 1,212 participants took part in the online poll ...
(Date:11/25/2008)...SUNNYVALE, Calif., Nov. 25 /PRNewswire-FirstCall/ ...nounced that the company has completed a Phase 1,..., first-in-class,small-molecule Factor VIIa inhib...lthy volunteers to evaluate the safety and pharmac...on of PCI-27483 resulted in a linear dose,respons...
Breaking Medicine Technology:St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Eighty Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche Chugais Actemra for Rheumatoid Arthritis 25050 1Eighty Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche Chugais Actemra for Rheumatoid Arthritis 25050 2Eighty Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche Chugais Actemra for Rheumatoid Arthritis 25050 3Aduromed Closes Restructuring and Raises 243 8 Million of New Equity Capital 25048 1Aduromed Closes Restructuring and Raises 243 8 Million of New Equity Capital 25048 2Aduromed Closes Restructuring and Raises 243 8 Million of New Equity Capital 25048 3GG One Software Announces iFastrack to Help Avoid Insurance Disasters 25046 1GG One Software Announces iFastrack to Help Avoid Insurance Disasters 25046 2Bederra Corp s Lumar Imaging Division Enters Into Joint Venture With Basic Solutions 25044 1Bederra Corp s Lumar Imaging Division Enters Into Joint Venture With Basic Solutions 25044 2
(Date:12/1/2008)...t computed tomography (CT) colonography, also know...een for two diseases at oncecolorectal cancer and ... over age 50. Results of the study will be present... Society of North America (RSNA). , "With CT col... cancer, we were able to identify patients with os...
(Date:12/1/2008)... -- It is a cold December day in,Memphis, Tenness...ner-up,Camilo Villegas and LPGA star Morgan Press...he impetus that has brought three of the biggest n... much more important than any game of,golf -- chi...ww.newscom.com/cgi-bin/prnh/20081201/CLM117 ) , ...
(Date:12/1/2008)...ire/ -- In the face of one of the most,severe eco...r Health Board of,Directors has approved an inves...nd the Sutter Health Retirement Plan. Employee pen...tocks and bonds, have been among the biggest,casu... conservatively,invested, the Sutter Health Retir...
(Date:12/1/2008)...ll/ - The Westaim Corporation today announced it h... of NUCRYST Pharmaceuticals Corp. to consider a re...mately US$15 million or US$0.80 per share. Westaim...the value of its 74.5 per cent stake in NUCRYST. U...T,s Board of Directors has 20 days to call a meeti...
Breaking Medicine News(10 mins):Health News:CT colonography offers 1-stop screening for cancer and osteoporosis 2Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 2Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 3Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 4Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 5Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 6Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 7Health News:Sutter Health Invests Hundreds of Millions in Employee Pension 2Health News:The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders 2
...s the risk of pancreatic cancer, but this can be m...ct to live for more than five years after pancreat...nown about how to prevent it (although smoking is ...o learn that you can do something to lower your ri...
...for relief of the pain and inflammation of osteoar...vely reducing the pain, inflammation and stiffness...ay with activities like standing, walking or climb...sitting or lying in bed. Since their introduction...
...idely used drugs in cardiovascular medicine.It imp...s in patients with cardiovascular conditions such ... drug produces dry cough as its most frequent side...th this troublesome complication discontinue the d...
... new way of administration of drug that treats mig...sodium "rapidly and forcefully" eases severe heada...f Anodyne PainCare in Dallas, in his study, which ...ed no relief after treatment with standard therapi...
Other Medicine News:
...int or DIP joint flexioncontractures of any degree... cushions injured fingers so treatment to straight...ster, more successful therapy results. Use during ...aintain gains in motion. Available in small, mediu...
...iation of the finger joints. Lined in gel padding ...ed splints can be worn at night to lessen stress o...owing injury to the PIP joint or DIP joint of the ...gament injuries. Each FingerSled Splint can be use...
FoamWrap Finger Trappers are ideal for use with custom made splints to help restore finger motion. Finger Trappers' non-slip foam lining replaces fingernail hooks and sutures to place the fingers in
One splint does it all.
Medicine Products: